Glioblastoma cancer stem cells – From concept to clinical application

Barbara E. Stopschinski; Christoph P. Beier; Dagmar Beier

doi:10.1016/j.canlet.2012.05.033

journal article Sep 01, 2013

Glioblastoma cancer stem cells – From concept to clinical application

Barbara E. Stopschinski

Christoph P. Beier Dagmar Beier

Cancer Letters Vol. 338 No. 1 pp. 32-40 · Elsevier BV

View at Publisher Save 10.1016/j.canlet.2012.05.033

Topics

No keywords indexed for this article. Browse by subject →

References

130

[1]

Stupp "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma" N. Engl. J. Med. (2005) 10.1056/nejmoa043330

[2]

Stupp "Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial" Lancet Oncol. (2009) 10.1016/s1470-2045(09)70025-7

[3]

Reya "Stem cells, cancer, and cancer stem cells" Nature (2001) 10.1038/35102167

[4]

Galli "Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma" Cancer Res. (2004) 10.1158/0008-5472.can-04-1364

[5]

Ignatova "Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro" Glia (2002) 10.1002/glia.10094

[6]

Singh "Identification of a cancer stem cell in human brain tumors" Cancer Res. (2003)

[7]

Clarke "Cancer stem cells – perspectives on current status and future directions: AACR workshop on cancer stem cells" Cancer Res. (2006) 10.1158/0008-5472.can-06-3126

[8]

Quintana "Efficient tumour formation by single human melanoma cells" Nature (2008) 10.1038/nature07567

[9]

Hamburger "Primary bioassay of human myeloma stem cells" J. Clin. Invest. (1977) 10.1172/jci108839

[10]

Hamburger "Primary bioassay of human tumor stem cells" Science (1977) 10.1126/science.560061

[11]

Park "Mouse myeloma tumor stem cells: a primary cell culture assay" J. Natl. Cancer Inst. (1971)

[12]

Identification of human brain tumour initiating cells

Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke et al.

Nature 2004 10.1038/nature03128

[13]

H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, H.I. Kornblum, Cancerous stem cells can arise from pediatric brain tumors, Proc. Natl. Acad. Sci. USA 100 (2003) 15178–15183. 10.1073/pnas.2036535100

[14]

T. Kondo, T. Setoguchi, T. Taga, Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proc. Natl. Acad. Sci. USA 101 (2004) 781–786. 10.1073/pnas.0307618100

[15]

Yuan "Isolation of cancer stem cells from adult glioblastoma multiforme" Oncogene (2004) 10.1038/sj.onc.1208311

[16]

Beier "CD133+ and CD133− glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles" Cancer Res. (2007) 10.1158/0008-5472.can-06-4180

[17]

Chen "A hierarchy of self-renewing tumor-initiating cell types in glioblastoma" Cancer Cell (2010) 10.1016/j.ccr.2009.12.049

[18]

Joo "Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas" Lab Invest. (2008) 10.1038/labinvest.2008.57

[19]

Prestegarden "Glioma cell populations grouped by different cell type markers drive brain tumor growth" Cancer Res. (2010) 10.1158/0008-5472.can-09-3904

[20]

Wang "CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells" Int. J. Cancer (2008) 10.1002/ijc.23130

[21]

Prestegarden "Cancer stem cells in the central nervous system – a critical review" Cancer Res. (2010) 10.1158/0008-5472.can-10-1592

[22]

Hermann "Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer" Cell Stem Cell (2007) 10.1016/j.stem.2007.06.002

[23]

Ricci-Vitiani "Identification and expansion of human colon-cancer-initiating cells" Nature (2007) 10.1038/nature05384

[24]

Shmelkov "CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors" J. Clin. Invest. (2008)

[25]

Kemper "The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation" Cancer Res. (2010) 10.1158/0008-5472.can-09-1820

[26]

Jeon "Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers" World J. Gastroenterol. (2010) 10.3748/wjg.v16.i25.3153

[27]

Bralten "IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo" Ann. Neurol. (2011) 10.1002/ana.22390

[28]

Hagerstrand "Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile" Neuro Oncol. (2011) 10.1093/neuonc/nor113

[29]

Gunther "Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria" Oncogene (2008) 10.1038/sj.onc.1210949

[30]

Pollard "Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens" Cell Stem Cell (2009) 10.1016/j.stem.2009.03.014

[31]

Son "SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma" Cell Stem Cell (2009) 10.1016/j.stem.2009.03.003

[32]

Wan "The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cells research" Brain Pathol. (2010) 10.1111/j.1750-3639.2010.00379.x

[33]

Ogden "Identification of A2B5+CD133− tumor-initiating cells in adult human gliomas" Neurosurgery (2008) 10.1227/01.neu.0000316019.28421.95

[34]

Lathia "Integrin alpha 6 regulates glioblastoma stem cells" Cell Stem Cell (2010) 10.1016/j.stem.2010.02.018

[35]

Read "Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma" Cancer Cell (2009) 10.1016/j.ccr.2008.12.016

[36]

Pistollato "Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma" Stem Cells (2010) 10.1002/stem.415

[37]

Seidel "A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha" Brain (2010) 10.1093/brain/awq042

[38]

Li "Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells" Cancer Cell (2009) 10.1016/j.ccr.2009.03.018

[39]

C.L. Chaffer, I. Brueckmann, C. Scheel, A.J. Kaestli, P.A. Wiggins, L.O. Rodrigues, M. Brooks, F. Reinhardt, Y. Su, K. Polyak, L.M. Arendt, C. Kuperwasser, B. Bierie, R.A. Weinberg, Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state, Proc. Natl. Acad. Sci. USA 108 (2011) 7950–7955. 10.1073/pnas.1102454108

[40]

Gupta "Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells" Cell (2011) 10.1016/j.cell.2011.07.026

[41]

Heddleston "Hypoxia inducible factors in cancer stem cells" Br. J. Cancer (2010) 10.1038/sj.bjc.6605551

[42]

Snuderl "Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma" Cancer Cell (2011) 10.1016/j.ccr.2011.11.005

[43]

Phillips "Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis" Cancer Cell (2006) 10.1016/j.ccr.2006.02.019

[44]

Lee "Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age" BMC Med. Genom. (2008) 10.1186/1755-8794-1-52

[45]

Verhaak "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1" Cancer Cell (2010) 10.1016/j.ccr.2009.12.020

[46]

Brennan "Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations" PLoS One (2009) 10.1371/journal.pone.0007752

[47]

Noushmehr "Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma" Cancer Cell (2010) 10.1016/j.ccr.2010.03.017

[48]

Hartmann "Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas" Acta Neuropathol. (2009) 10.1007/s00401-009-0561-9

[49]

Piaskowski "Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions" Br. J. Cancer (2011) 10.1038/bjc.2011.27

[50]

Luchman "An in vivo patient-derived model of endogenous IDH1-mutant glioma" Neuro Oncol. (2012) 10.1093/neuonc/nor207

Showing 50 of 130 references

Cited By

63

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells

Olga Pastorino, Maria Teresa Gentile · 2019

Cancers

Metrics

63

Citations

130

References

Details

Published: Sep 01, 2013
Vol/Issue: 338(1)
Pages: 32-40
License: View

Authors

B

Barbara E. Stopschinski

Cite This Article

Barbara E. Stopschinski, Christoph P. Beier, Dagmar Beier (2013). Glioblastoma cancer stem cells – From concept to clinical application. Cancer Letters, 338(1), 32-40. https://doi.org/10.1016/j.canlet.2012.05.033

Glioblastoma cancer stem cells – From concept to clinical application

You May Also Like